Total and high molecular weight adiponectin in patients with coronary artery disease

Journal of Cardiovascular Medicine

Volumn 10, Issue 4, 2009, Pages 310-315

  El Menyar, Ayman ^a,c   Rizk, Nasser ^b   Al Nabti, Abdulrahman D ^a,c   Hassira, Sana Abu ^b   Singh, Rajvir ^a   Abdel Rahman, Mohamed Osman ^a   Suwaidi, Jassim Al ^a,c  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b QATAR UNIVERSITY   (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Adiponectin; Anti inflammatory; Coronary artery disease; HMW adiponectin

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, HUMAN; IL6 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PERIPHERAL VEIN; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING;

ACUTE CORONARY SYNDROME; ADIPONECTIN; ADULT; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; INSULIN; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66149123619     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283252b50     Document Type: Article

References (34)

1. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2:536-543. (Pubitemid 41670345)
2. Wolk R, Berger P, Lennon RJ, Brilakis ES, Davison DE, Somers VK. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007; 28:292-298. (Pubitemid 46254633)
3. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296-1301. (Pubitemid 30728130)
4. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96:1723-1732. (Pubitemid 30661055)
5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al., Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23:85-89.
6. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischaemic stroke. Stroke 2005; 36:1915-1919.
7. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291:1730-1737. (Pubitemid 38489895)
8. Takano H, Obata JE, Kodama Y, Kitta Y, Nakamura T, Mende A, et al. Adiponectin is released from the heart in patients with heart failure. Int J Cardiol 2008. [Epub ahead of print]
9. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257:79-83. (Pubitemid 29299050)
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20:1595-1599. (Pubitemid 30353893)
11. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, et al. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004; 53:1621-1629. (Pubitemid 38697679)
12. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90:528-533. (Pubitemid 38530170)
13. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Matsui K, et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 2006; 48:1155-1162. (Pubitemid 44345143)
14. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14:561-566. (Pubitemid 41623184)
15. von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, et al. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008; 199:123-128. (Pubitemid 351842696)
16. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, et al., Osaka CAD group. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J 2008; 72:23-28.
17. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120:803-812. (Pubitemid 26385421)
18. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279:12152-12162. (Pubitemid 38445780)
19. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al. Selective suppression of endothelial cell apotosis by the high molecular weight form of adiponectin. Circ Res 2004; 94:e27-e31.
20. Nakano Y, Tajima S, Yoshimi A, Akiyama H, Tsushima M, Tanioka T, et al. A novel enzyme-linked immunosorbent assay specific for high-molecular weight adiponectin. J Lipid Res 2006; 47:1572-1582. (Pubitemid 44079912)
21. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, et al. Comparison of serum high-molecular weight (HMW) adiponectin concentration in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006; 55:1954-1960.
22. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte secreted hormone Acrp30/ adiponectin: implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278:9073-9085. (Pubitemid 36800387)
23. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278:40352-40363. (Pubitemid 37248604)
24. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51:2734-2741. (Pubitemid 34970926)
25. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280:18073-18080. (Pubitemid 41389052)
26. Stejskal D, Bartek J. adiponectin in patients with various stages of coronary heart disease - comparison of its concentration in coronary arteries and peripheral venous circulation. Biomed Papers 2003; 147:161-166.
27. Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007; 100:569-574. (Pubitemid 47223129)
28. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32:47-50. (Pubitemid 30143606)
29. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103:1057-1063. (Pubitemid 32200177)
30. Cavusoglu E, Chopra V, Battala V, Ruwende C, Yanamadala S, Eng C, et al. Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography. Am J Cardiol 2008; 101:1073-1078.
31. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007; 42:1065-1074. (Pubitemid 46829193)
32. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29:251-255. (Pubitemid 40320925)
33. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, et al. Blockade of the renin angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42:76-81. (Pubitemid 36842239)
34. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008. [Epub ahead of print]